beta-thujone has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catapano, J; Czyż, J; Janik-Olchawa, N; Kochanowski, P; Mrowiec, K; Pudełek, M; Ryszawy, D | 1 |
| Carrasco, C; Oyarzún, C; Quezada, C; Rocha, R; San Martín, R; Torres, A; Torres, C; Uribe, D; Vargas, Y | 1 |
2 other study(ies) available for beta-thujone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Therapeutic potential of monoterpene α-thujone, the main compound of Thuja occidentalis L. essential oil, against malignant glioblastoma multiforme cells in vitro.
Topics: Apoptosis; Bicyclic Monoterpenes; Cell Line, Tumor; Cell Survival; Glioblastoma; Humans; Monoterpenes; Oils, Volatile; Thuja | 2019 |
Pro-apoptotic and anti-angiogenic properties of the α /β-thujone fraction from Thuja occidentalis on glioblastoma cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Bicyclic Monoterpenes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Male; Monoterpenes; Neoplasm Transplantation; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Thuja | 2016 |